Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

News Focus

SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Baudax Bio Inc BXRXQ

Healthcare

Baudax Bio, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products for hospital and related acute care settings. The Company's lead product candidate is ANJESO injection. ANJESO is a cyclooxygenase-2 (COX-2), a preferential, non-steroidal anti-inflammatory for the management of moderate to severe pain, which could be administered alone or in... see more

Add To Watchlist

Bullboard (PINL:BXRXQ)

View:

Post by Iseneschalon Jun 30, 2023 11:05am

BXRX....Halted again on the way down

In PB mode now.....me no position Cheers and GLTA

66

Post by Iseneschalon Jun 30, 2023 10:58am

BXRX.....3rd scalp..... I'm done now

going camping ....Cheers !

64

Lahontan Completes Phase Two of 2024 Drilling at Santa Fe

posted Jun 25, 2024 9:00am by Lahontan Gold Corp.

"Lahontan is excited to complete the second Phase of our 2024 drilling campaign at Santa Fe. The drilling was completed rapidly and under budget, a tribute to our geologic team and the excellent drill crew. Work on the PEA continues at an accelerating pace, with site visits, scoping studies on capex and operating costs underway. We will continue to update investors as the PEA progresses and when assay results from the 2024 drilling program are received". ...read more

Post by Iseneschalon Jun 30, 2023 10:53am

BXRX....Volume & price action..Love it

Here i go pumping..... But ...wouldn't surprise me to see this get to the DTL trend line..... somewhere around ~ $2

72

Post by Iseneschalon Jun 30, 2023 10:47am

BXRX..... Halted again....on the rising swell upward

This has a history of big intra-day swings Trade accordingly ; )

58

Post by Iseneschalon Jun 30, 2023 10:44am

BXRX.....Ride the wave ; )

What a rip

55

Post by Iseneschalon Jun 30, 2023 10:30am

BXRX ....Now did you just see that !!!!!!!!!!!!!

WTF

76

Post by Iseneschalon Jun 30, 2023 10:28am

BXRX.....2nd scalp ; )

More profit .... Cheers !

42

Post by Iseneschalon Jun 30, 2023 10:27am

BXRX ....all the TA's see that big gap

good luck

43

Post by Iseneschalon Jun 30, 2023 10:22am

BXRX .....NIce scalp!

Never did get down to 60.....bot some at 65...........sold at 78 Thanks for the great profit !!!!

45

Post by Iseneschalon Jun 30, 2023 9:38am

BXRX.... LMFAO....Has to hold 60 pesos or

it's done What a game

61

Post by Iseneschalon Jun 30, 2023 9:28am

BXRX....what it going to be

Instant Retail face rip.....or rally?

46

Post by PressReleaseon May 12, 2023 8:32am

New Press Release - Baudax Bio Reports First Quarter Financial Results and Provides Business Update

Announced Positive Top-Line Final Results from Phase 2 Randomized Clinical Trial of BX1000 Hosted Key Opinion Leader Webinar to Highlight Potential of BX1000 and Neuromuscular Blocking Agent Portfolio Secured $4 Million in Gross Proceeds from Public Offering in MayMALVERN, Pa., May 12, 2023...read article.

Post by PressReleaseon May 03, 2023 4:05pm

New Press Release - Baudax Bio to Present at the Sidoti Virtual Investor Conference

MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq:BXRX) (the “Company”), a pharmaceutical company focused on innovative products for hospital and related settings, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present and host...read article.

Post by PressReleaseon May 01, 2023 5:43pm

New Press Release - Baudax Bio Announces Closing of $4 Million Public Offering

MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a pharmaceutical company focused on innovative products for hospital and related settings, today announced the closing of its previously announced public offering of an aggregate of 3...read article.

Post by Iseneschalon Apr 27, 2023 9:04am

BXRX....see my previous post

Down a ton in the Pre-Market open.....No kidding.....the timing of the events are very suspect. Maddapakkas !!!! No position

42

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities

Featured News Links

How a truck transportation and logistics company leverages acquisitions and technology

High-grade gold potential in the world’s best mining jurisdiction

Undervalued Oil & Gas Play Readies for Strong H2 2024 with Canadian and US Assets